Status:

UNKNOWN

Efficacy of PC6 Electroacupuncture in the Prevention of Nausea Vomiting in Caesarean Patient Under Spinal Anaesthesia

Lead Sponsor:

Clinical Research Centre, Malaysia

Conditions:

Postoperative Nausea and Vomiting

Eligibility:

FEMALE

18-45 years

Phase:

NA

Brief Summary

To determine the ability of electroacupuncture on PC6 versus sham acupuncture in reducing incidence of intraoperative and postoperative nausea vomiting in parturients who underwent Caesarean delivery ...

Detailed Description

Caesarean rate in most countries are increasing year by year. A report shows that the caesarean section rate for government hospitals in Malaysia was 10.5% in 2000 and 11.0% in 20011 and it rises to 2...

Eligibility Criteria

Inclusion

  • Parturients (36-42 weeks pregnant) aged 18-45 undergoing planned for Caesarean Section.
  • American Society of Anaesthesiology class II patients only

Exclusion

  • Patients with a previous history of PONV or nausea and vomiting in the preceding 24 hours
  • Patients who required emergent surgery where delay is inappropriate and can compromise mother and foetus, e.g. foetal distress, foetal bradycardia, chorioamnionitis, cord prolapse, severe preeclampsia
  • Patients with documented or known history of allergy to granisetron
  • Morbid obesity (BMI\>40) as morbid obesity patient will be not be given intrathecal morphine due to increase risk of post operative respiratory depression.
  • Patients using any antiemetic drug including dexamethasone for 24 hours prior to Caesarean section (CS)
  • Patient who had an implanted pacemaker or defibrillator device. (safety of the use of electroacupuncture on these patient is questionable)
  • Patient who received opioids prior to CS (opioid is known to have nausea and vomiting side effect)
  • Patient refusal
  • Severe preeclampsia, gestational diabetes mellitus on treatment, neurological or cardiac disease.

Key Trial Info

Start Date :

September 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 30 2021

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT04801277

Start Date

September 1 2020

End Date

April 30 2021

Last Update

March 16 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital Raja Permaisuri Bainun Ipoh

Ipoh, Perak, Malaysia, 30450